Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Verona Pharma Plc ADR (NASDAQ: VRNA) closed at $69.14 down -1.33% from its previous closing price of $70.07. In other words, the price has decreased by -$1.33 from its previous closing price. On the day, 1.09 million shares were traded.
Ratios:
For a deeper understanding of Verona Pharma Plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.73 and its Current Ratio is at 8.86. In the meantime, Its Debt-to-Equity ratio is 1.08 whereas as Long-Term Debt/Eq ratio is at 1.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on April 28, 2025, initiated with a Buy rating and assigned the stock a target price of $100.
On April 21, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $80.
On January 10, 2025, ROTH MKM started tracking the stock assigning a Buy rating and target price of $68.ROTH MKM initiated its Buy rating on January 10, 2025, with a $68 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 06 ’25 when KATHLEEN RICKARD bought 14,373 shares for $72.25 per share.
Rickard Kathleen A. sold 49,200 shares of VRNA for $440,350 on May 01 ’25. The Chief Medical Officer now owns 2,633,320 shares after completing the transaction at $8.95 per share. On May 02 ’25, another insider, Hahn Mark W, who serves as the Chief Financial Officer of the company, sold 400,000 shares for $9.09 each. As a result, the insider received 3,637,720 and left with 13,078,992 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 49.65 while its Price-to-Book (P/B) ratio in mrq is 25.98.
Stock Price History:
Over the past 52 weeks, VRNA has reached a high of $74.18, while it has fallen to a 52-week low of $11.39. The 50-Day Moving Average of the stock is 8.18%, while the 200-Day Moving Average is calculated to be 54.91%.
Shares Statistics:
A total of 85.13M shares are outstanding, with a floating share count of 74.63M. Insiders hold about 12.34% of the company’s shares, while institutions hold 70.98% stake in the company.
